MedPath

Biogen Ma Inc.

🇺🇸United States
Ownership
Subsidiary
Employees
2.6K
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 4:1

Drug Approvals

2

NMPA:1
FDA:1

Drug Approvals

Tofersen Injection

Product Name
凯盛迪
Approval Number
国药准字HJ20240102
Approval Date
Sep 26, 2024
NMPA

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 4
1 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.